Blockbuster Weight-Loss Drugs & Cancer Risk: Ozempic Can Affect Pancreas Cells, Experts Weigh In On Whether That’s Worrisome
For people taking GLP-1 drugs, such as the mega-popular weight-loss drug Ozempic (semaglutide) — intended for type 2 diabetes patients and people with obesity — there has been some concern about the effects on the pancreas and whether or not there is a potential risk of pancreatic cancer for people using these medications.
Blockbuster Weight-Loss Drugs & Cancer Risk: Ozempic Can Affect Pancreas Cells, Experts Weigh In On Whether ThatÕs Worrisome
For people taking GLP-1 drugs, such as the mega-popular weight-loss drug Ozempic (semaglutide) Ñ intended for type 2 diabetes patients and people with obesity Ñ there has been some concern about the effects on the pancreas and whether or not there is a potential risk of pancreatic cancer for people using these medications.
New Hope For Bladder Cancer Patients Like Broadcaster Terry Bradshaw; Saving The Bladder & Avoiding Cancer Spread With A New Protocol
An ongoing clinical trial is suggesting that a certain type of treatment for muscle-invasive bladder cancer—noadjuvant chemoimmunotherapy followed by risk-adapted therapy—offered better rates of metastasis-free survival and helped patients keep their bladders.
The Promise of CAR-T Cell Therapy in the Multiple Myeloma Treatment Paradigm
'A Deep and Durable Response' CAR T-cell therapy is a one-time treatment that is both a drug and procedure. A patient’s immune system’s T cells are ex…
FDA Proposes New Testing Methods to Check Talc-Containing Cosmetic Products for Cancer-Linked Ingredient — Asbestos & Cancer Risk
The FDA has proposed a rule to make necessary testing methods to detect asbestos, a known carcinogen, in talc-containing cosmetic products.
Grandmother, 53, Beat Stage 4 HER2-Positive Breast Cancer With Immunotherapy After Being Told To 'Enjoy The Time You Have Left'
Grandmother Tina Willits, 53, beat HER2-positive breast cancer and she's praising an immunotherapy treatment for saving her life.
